An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
Clinical Trials Related to Generalized Myasthenia Gravis
Related studies linked through entity extraction aliases.
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
- Status
- RECRUITING
- Phase
- NA
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2/PHASE3
Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis
- Status
- WITHDRAWN
- Phase
- PHASE2
An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis
- Status
- TERMINATED
- Phase
- PHASE3
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3